- •
Rift Valley fever (RVF) is an important human and veterinary pathogen that causes significant illness and death.
- •
The life cycle of RVF is complex and involves mosquitoes, livestock, climate, and humans.
- •
RVF virus is transmitted from either mosquitoes or animals to humans, but is generally not transmitted from person to person.
- •
There is a significant risk of emergence of RVF into new locations, which would affect human health and livestock industries.
- •
There are no approved vaccines or therapeutics
Rift Valley Fever
Section snippets
Key points
Overview
One Health is a concept that recognizes the inextricable linkages between human health, animal health, and the environment (Fig. 1). Rift Valley fever (RVF) is a long-recognized veterinary disease of livestock in Africa. Infection with RVF virus (RVFV) causes a highly lethal illness in domesticated livestock (sheep, cattle, and goats) that consequently has dire economic impacts in affected regions. RVF has been and remains on the World Organization for Animal Health’s list of notifiable animal
Microbiology
RVFV is one of the most important members of the large and diverse Bunyaviridae family. RVFV belongs to the Phlebovirus genus, which also contains other viruses including Punta Toro, Sandfly fever, and severe fever with thrombocytopenia syndrome virus. The name phleobovirus is derived from the fact that most of the viruses in this genus are transmitted by phlebotomine sandflies. RVFV is a notable exception because it is transmitted primarily by mosquitoes. All bunyaviruses, including RVFV,
Epidemiology
The epidemiology of RVFV is complex and involves multiple players, including mosquitoes, wild animals, domesticated livestock, and humans (Fig. 2).
Biosafety and biodefense concerns
Of note, a significant number of accidental infections with RVFV have occurred among people performing diagnostic testing or those working with the virus in animals or the laboratory.39, 40, 41, 42, 43 At least 25 accidental infections occurred through 1949,39 with a total of 47 to date. Many of these infections were traced to aerosol (inhalational) exposure.39, 40 These laboratory-acquired infections led to early knowledge about the disease course in humans.
The United States, Canada, Japan,
Livestock
The clinical disease of RVF in domesticated animals is described in Table 3.2, 57, 58, 59 At all stages of gestation, infection of pregnant domesticated animals will result in near 100% death of the fetuses. Adult livestock are susceptible to peracute disease, which is defined as the occurrence of death before the development of any clinical signs. Adult livestock can also develop acute disease characterized by weakness, anorexia, diarrhea, bloody nasal discharge, and jaundice. The mortality
Diagnosis
In endemic regions, human illness soon follows in areas where there is concurrent RVF disease in animals, so monitoring of herds and efficient reporting is critical. Blood samples from acutely infected people can be tested for the presence of virus by either reverse transcriptase polymerase chain reaction, antigen-detection enzyme-linked immunosorbent assay, or isolation of live virus. After the cessation of viremia, immunoglobulin (Ig)M can be detected transiently. Recovered patients will have
Treatment and prevention
There are no specific, Food and Drug Administration-approved treatments for RVF. Treatment of symptoms such as fever and body aches can be done with standard over-the-counter medications. Care of hospitalized patients is supportive, including fluid replacement. Drugs that affect the liver, kidney, or coagulation should be avoided.
Prevention of animal and human outbreaks
The first step in the prevention of significant human disease is early detection of cases in animals through rigorous active surveillance and sentinel herd monitoring.96 Once infected animals and/or herds are located, further spread can be prevented by mosquito control, animal movement control, ban on livestock slaughtering, or at least use of preventative measures (gloves, masks, and gowns) when handling carcasses or aborted fetuses. Public awareness and education as to the signs, symptoms,
Potential for emergence
RVFV has spread throughout Africa, to the island of Madagascar, and into the Saudi Arabian peninsula. Most recently, endemic RVF was discovered in both Angola and Nigeria.98 Notably, human cases have not yet been recognized in these areas, potentially owing to focus on other diseases such as malaria, Yellow fever, and Dengue.
Concern over the further spread of RVF outside of Africa or the Saudi Arabian peninsula stems from the unexpected expansion of other arboviruses, namely West Nile,
Summary
RVF is a One Health disease that highlights the need to consider climate, veterinary health, and human behavior to prevent future outbreaks. Prevention of significant epizootics and epidemics is important in endemic areas owing to the severe economic impact. Also critical is prevention of spread to new areas.
References (112)
- et al.
Immunoelectron microscopy of Rift Valley fever viral morphogenesis in primary rat hepatocytes
Virology
(1987) - et al.
Possible vectors of Rift Valley fever in Kenya
Trans R Soc Trop Med Hyg
(1980) - et al.
Epidemic Rift Valley fever in Egypt: observations of the spectrum of human illness
Trans R Soc Trop Med Hyg
(1979) - et al.
Ocular complications of Rift Valley fever outbreak in Saudi Arabia
Ophthalmology
(2005) - et al.
Recurrence of Rift Valley fever in Egypt
Lancet
(1993) - et al.
Breaking the chain: Rift Valley fever virus control via livestock vaccination
Curr Opin Virol
(2012) - et al.
Immunogenicity and safety of an inactivated Rift Valley fever vaccine in a 19-year study
Vaccine
(2011) - et al.
Safety and immunogenicity of recombinant Rift Valley fever MP-12 vaccine candidates in sheep
Vaccine
(2013) - et al.
Safety and immunogenicity of a mutagenized, live attenuated Rift Valley fever vaccine, MP-12, in a Phase 1 dose escalation and route comparison study in humans
Vaccine
(2016) - et al.
Rift Valley fever MP-12 vaccine phase 2 clinical trial: safety, immunogenicity, and genetic characterization of virus isolates
Vaccine
(2016)
Immunogenicity of an inactivated Rift Valley fever vaccine in humans: a 12-year experience
Vaccine
Immunogenicity of a recombinant Rift Valley fever MP-12-NSm deletion vaccine candidate in calves
Vaccine
One health approach to Rift Valley fever vaccine development
Antiviral Res
Potency of a thermostabilised chimpanzee adenovirus Rift Valley Fever vaccine in cattle
Vaccine
Enzootic hepatitis or Rift Valley fever: an undescribed virus disease of sheep, cattle, and man from east Africa
J Pathol Bacteriol
Present and future arboviral threats
Antiviral Res
Rift Valley fever–a threat for Europe?
Euro Surveill
Potential effects of Rift Valley fever in the United States
Emerg Infect Dis
A temperature-limited assessment of the risk of Rift Valley fever transmission and establishment in the continental United States of America
Geospat Health
7 CFR Part 331 and 9 CFR Part 121. Agricultural Bioterrorism Protection Act of 2002; possession, use, and transfer of biological agents and toxins; final rule
Fed Reg
42 CFR parts 72, 73 and 42 CFR part 1003. Posession, use, and transfer of Select agents and toxins; final rule
Fed Reg
Blueprint for R&D preparedness and response to public health emergencies due to highly infectious pathogens
Unfilled Vials: scientifically feasible vaccines against major diseases are stalled for lack of funds
Science
The hexamer structure of Rift Valley fever virus nucleoprotein suggests a mechanism for its assembly into ribonucleoprotein complexes
PLoS Pathog
The N terminus of Rift Valley fever virus nucleoprotein is essential for dimerization
J Virol
Multiple virus lineages sharing recent common ancestry were associated with a Large Rift Valley fever outbreak among livestock in Kenya during 2006-2007
J Virol
Complete genome analysis of 33 ecologically and biologically diverse Rift Valley fever virus strains reveals widespread virus movement and low genetic diversity due to recent common ancestry
J Virol
Genetic reassortment of Rift Valley fever virus in nature
J Virol
Rift Valley fever: an emerging mosquito-borne disease
Annu Rev Entomol
Arboviruses: case studies of transmission: Rift Valley fever virus
New vectors of Rift Valley fever in West Africa
Emerg Infect Dis
Rift Valley fever affecting humans in South Africa: a clinicopathological study
S Afr Med J
Rift Valley fever virus (family Bunyaviridae, genus Phlebovirus). Isolations from Diptera collected during an inter-epizootic period in Kenya
J Hyg (Lond)
Rainfall and epizootic Rift Valley fever
Bull World Health Organ
Isolation of Rift Valley fever virus from bats in the Republic of Guinea
Bull Soc Pathol Exot Filiales
Rift Valley fever virus among wild ruminants, Etosha National Park, Namibia, 2011
Emerg Infect Dis
Rift Valley fever in Kenya: the presence of antibody to the virus in camels (Camelus dromedarius)
J Hyg (Lond)
Rift Valley fever. 1. Vector studies in the field
J S Afr Vet Med Assoc
Factors associated with severe human Rift Valley fever in Sangailu, Garissa County, Kenya
PLoS Negl Trop Dis
Risk factors for severe Rift Valley fever infection in Kenya, 2007
Am J Trop Med Hyg
Rift Valley fever epidemic in Saudi Arabia: epidemiological, clinical, and laboratory characteristics
Clin Infect Dis
Rift Valley fever in South Africa. 2. The occurrence of human cases in the Orange Free State, the North-Western Cape Province, the Western and Southern Transvaal. B. Field and laboratory investigation
S Afr Med J
Rift Valley fever in humans in South Africa
S Afr Med J
Rift Valley fever and a new paradigm of research and development for zoonotic disease control
Emerg Infect Dis
Rift Valley fever: a sero-epidemiological survey among pregnant women in Mozambique
Epidemiol Infect
Case report: Rift Valley fever with vertical transmission in a pregnant Sudanese woman
J Med Virol
Vertical transmission of fatal Rift Valley fever in a newborn
Ann Trop Paediatr
Cited by (80)
-
Exotic viral hepatitis: A review on epidemiology, pathogenesis, and treatment
2022, Journal of HepatologyCitation Excerpt :Rift Valley fever virus (RVFV) was first identified in 1930 during an investigation into an outbreak among sheep on a farm in Kenya’s Rift Valley.71 RVFV belongs to the order of Bunyaviridae, and is endemic in several African countries, as well as in the Arabian Peninsula (Fig. 1).4,71 Outbreaks occur regularly, with an estimated 200,000 human infections during the largest recent outbreak (in Egypt 1977-1979).
-
First detection of Rift Valley fever virus antibodies in non-human primates in Cameroon
2024, Journal of Medical Primatology -
Systemic and Ocular Manifestations of Arboviral Infections: A Review
2024, Ocular Immunology and Inflammation -
Brilacidin as a Broad-Spectrum Inhibitor of Enveloped, Acutely Infectious Viruses
2024, Microorganisms